The nociceptin/orphanin FQ receptor agonist SR-8993 as a candidate therapeutic for alcohol use disorders: validation in rat models.
about
Influence of stress associated with chronic alcohol exposure on drinking.A novel and selective nociceptin receptor (NOP) agonist (1-(1-((cis)-4-isopropylcyclohexyl)piperidin-4-yl)-1H-indol-2-yl)methanol (AT-312) decreases acquisition of ethanol-induced conditioned place preference in mice.Advances in Pharmacotherapy Development: Human Clinical Studies.Anti-stress neuropharmacological mechanisms and targets for addiction treatment: A translational framework
P2860
The nociceptin/orphanin FQ receptor agonist SR-8993 as a candidate therapeutic for alcohol use disorders: validation in rat models.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The nociceptin/orphanin FQ rec ...... ers: validation in rat models.
@en
The nociceptin/orphanin FQ rec ...... ers: validation in rat models.
@nl
type
label
The nociceptin/orphanin FQ rec ...... ers: validation in rat models.
@en
The nociceptin/orphanin FQ rec ...... ers: validation in rat models.
@nl
prefLabel
The nociceptin/orphanin FQ rec ...... ers: validation in rat models.
@en
The nociceptin/orphanin FQ rec ...... ers: validation in rat models.
@nl
P2093
P2860
P1433
P1476
The nociceptin/orphanin FQ rec ...... ers: validation in rat models.
@en
P2093
Abdul Maruf Asif Aziz
Annika Thorsell
Claes Wahlestedt
Gregory Sartor
Lovisa Holm
Markus Heilig
Shaun Brothers
P2860
P2888
P304
P356
10.1007/S00213-016-4385-8
P577
2016-08-11T00:00:00Z